Can tighter blood pressure control in pregnancy prevent serious complications?

NCT ID NCT07746271

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This trial tests whether treating high blood pressure in pregnancy to a stricter target (below 140/90) is better than the usual approach (below 160/110) for women with gestational hypertension or preeclampsia without severe features. About 4,120 pregnant women will be randomly assigned to one of the two blood pressure goals. The study tracks whether the stricter goal reduces a combined set of serious outcomes, including organ damage, early delivery, fetal or infant death, and placental abruption.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Antihypertensive medication (labetalol or nifedipine ER) titrated to a blood pressure goal of <140/90 mmHg
What this could lead to
If tighter blood pressure control works, it could reduce serious pregnancy complications like preterm birth and organ damage in women with gestational hypertension or preeclampsia.
What could go wrong
The trial is large but open-label, and the tighter goal may increase side effects from medication without improving outcomes. Results are not yet available.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION IN PREGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Baylor College of Medicine

    Houston, Texas, 77030, United States

  • Brown Univeristy

    Providence, Rhode Island, 02905, United States

  • Case Western Reserve University

    Cleveland, Ohio, 44109, United States

  • Columbia University

    New York, New York, 10032, United States

  • Duke University

    Durham, North Carolina, 27710, United States

  • Magee Women's Hospital

    Pittsburgh, Pennsylvania, 15213, United States

  • Northwestern University

    Chicago, Illinois, 60611, United States

  • Ohio State University

    Columbus, Ohio, 43210, United States

  • Regents of the University of California San Francisco

    San Francisco, California, 94143, United States

  • University of Alabama - Birmingham

    Birmingham, Alabama, 35233, United States

  • University of North Carolina - Chapel Hill

    Chapel Hill, North Carolina, 27599, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, 19104, United States

  • University of Texas - Houston

    Houston, Texas, 77030, United States

  • University of Utah

    Salt Lake City, Utah, 84132, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.